reduced-intensity transplant conditioning procedure

OTHER2 trials

Conditions

Chronic Myeloproliferative DisordersLeukemiaLymphomaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsNonmalignant Neoplasm

Phase 1

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

WithdrawnNCT00816413

University of NebraskaChronic Myeloproliferative Disorders, Leukemia, Lymphoma +2

Start: 2008-09-30End: 2010-02-28Updated: 2023-08-14

Phase 2

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

TerminatedNCT01118013

Alliance for Clinical Trials in OncologyLeukemia, Lymphoma, Lymphoproliferative Disorder +3

Start: 2010-12-31End: 2013-08-31Updated: 2017-03-24

reduced-intensity transplant conditioning procedure

Sponsors

Conditions

Phase 1

Phase 2